Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

27.07.15	Sanofi: Genzyme Strengthens Endocrinology Portfolio with Acquisition of Rare Disease Therapy Caprelsa® (vandetanib) from AstraZeneca (GlobeNewswire)
24.07.15	Sanofi: FDA Okays Praluent To Treat Certain Patients With High Cholesterol (RTTNews)
24.07.15	Sanofi and Regeneron Announce FDA Approval of Praluent® (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients (GlobeNewswire)
24.07.15	Regeneron:CHMP Recommends EU Approval Of Praluent To Treat Hypercholesterolemia (RTTNews)
24.07.15	Sanofi and Regeneron Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia (GlobeNewswire)
15.07.15	Sanofi Reduces Business Units To Five To Drive Growth (RTTNews)
10.07.15	Merial Launches Oravet Dental Hygiene Chews For Dogs - Quick Facts (RTTNews)
09.07.15	Aethlon To Be Uplisted To NASDAQ, CLLS Hits Milestone, LXK Gets FDA Nod (RTTNews)
09.07.15	Regeneron:Phase3 Odyssey Japan Trial Of Praluent Injection Met Primary Endpoint (RTTNews)
02.07.15	Sanofi Signs Deal With SUEZ Environnement To Enhance Water And Waste Management (RTTNews)
16.06.15	AERI Rockets On FDA Feedback, ADXS On The Job, ITCI To Report Trial Data In Q3 (RTTNews)
15.06.15	Genzyme Begins Phase 1/2 Trial To Evaluate Olipudase Alfa In Pediatric Patients (RTTNews)
10.06.15	FDA Panel Backs REGN's Cholesterol Drug, SAGE Cheered Up, Keep Watch Over TXMD (RTTNews)
10.06.15	FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia (GlobeNewswire)
06.06.15	Sanofi's Lyxumia Meets All Co-primary Endpoints In GetGoal Duo-2 Trial (RTTNews)
04.06.15	Sanofi Announces Program Of Phase IV Clinical Trials To Study Toujeo (RTTNews)
04.06.15	Genzyme Says FDA Grants Breakthrough Therapy Designation For Its Olipudase Alfa (RTTNews)
26.05.15	Genzyme to Present Aubagio® (teriflunomide) and Lemtrada® (alemtuzumab) Data at CMSC (Businesswire)
26.05.15	NeuroVive Asia Inks Collaboration Deal With Sanofi For Growth Of CicloMulsion (RTTNews)
21.05.15	Regeneron, Sanofi Report Positive Phase 3 Study Results Of Sarilumab In RA (RTTNews)
13.05.15	Sanofi Exercises Option On 2nd Therapeutic Program With Selecta Biosciences (RTTNews)
30.04.15	Sanofi Q1 Profit Down, Sales Up - Quick Facts (RTTNews)
30.04.15	Sanofi delivers Q1 2015 Business EPS(1) growth of 2.6% at CER(2) and 12.8% on a reported basis (GlobeNewswire)
28.04.15	Sanofi : Toujeo Approved In EU To Treat Diabetes In Adults (RTTNews)
28.04.15	FDA Grants Fast Track Designation To Genzyme's GZ/SAR402671 - Quick Facts (RTTNews)
22.04.15	MSTX Study Crosses Halfway Mark, VASC Blooms, ALL Is Well With PFE (RTTNews)
16.04.15	Innate Pharma, Sanofi Collaborate On ADC Using Site-specific Conjugation Tech (RTTNews)
31.03.15	AMGN To Face FDA, BDSI Fails To Deliver, 'Twas A Merger Monday (RTTNews)
30.03.15	Genzyme's Cerdelga Capsules Approved In Japan - Quick Facts (RTTNews)
26.03.15	Genzyme Convenes Sixth Annual Gaucher Leadership Forum (Businesswire)
26.03.15	EBS, REGN Get FDA Nod, OVAS To Deliver, Recro Recuperates, Watch Out For ZSAN (RTTNews)
26.03.15	Genzyme Announces Publication Of Results From ENCORE Study (RTTNews)
25.03.15	Sanofi: FDA Okays Quadracel DTaP-IPV Vaccine For Children (RTTNews)
19.03.15	Sanofi Announces Top-Line Results for Cardiovascular Outcomes Study of Lyxumia® (lixisenatide) (GlobeNewswire)
15.03.15	Sanofi Announces 18-Month Results Of ODYSSEY LONG TERM Trial With Praluent (RTTNews)
15.03.15	Sanofi, Regeneron: 18-Month Results of ODYSSEY LONG TERM Trial with Praluent(TM) (alirocumab) Published in The New England Journal of Medicine (GlobeNewswire)
01.03.15	New Drug Approvals - The Month That Was (RTTNews)
27.02.15	Toujeo® Receives Positive Opinion from the European Regulatory Authorities (GlobeNewswire)
26.02.15	Sanofi Gets FDA Approval Of Once-Daily Basal Insulin Toujeo (RTTNews)
26.02.15	Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo® (GlobeNewswire)
20.02.15	Sanofi Names Bayer Executive Olivier Brandicourt As New CEO (RTTNews)
18.02.15	Sanofi Enters Research Collaboration And License Agreement With Lead Pharma (RTTNews)
12.02.15	Genzyme Presents Data from its Phase 1b Program for Niemann-Pick Type B at the Lysosomal Disease Network’s WORLD Symposium 2015 (Businesswire)
12.02.15	Genzyme Presents Late-stage Clinical Trial Extension Results For Cerdelga (RTTNews)
05.02.15	Sanofi Q4 Profit Rises As Sales Jump In US, Emerging Markets (RTTNews)
05.02.15	Sanofi Q4 Profit, Revenue Rise - Quick Facts (RTTNews)
03.02.15	Sanofi And MannKind Say Inhaled Insulin Afrezza Now Available In U.S. (RTTNews)
03.02.15	Sanofi : Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S. (GlobeNewswire)
26.01.15	Regeneron Pharma, Sanofi Say FDA Accepted For Priority Review BLA For Praluent (RTTNews)
19.01.15	Sanofi: European Commission Approves Merial's NexGard Spectra - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

29.12.24		Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen
29.12.24		Roche-CEO bescheinigt Pharmakonzern gesundes Geschäft
27.12.24		Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag
27.12.24		Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste
27.12.24		Freitagshandel in Frankfurt: LUS-DAX zeigt sich letztendlich fester

29.12.24

Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen

29.12.24

Roche-CEO bescheinigt Pharmakonzern gesundes Geschäft

27.12.24

Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus

27.12.24

BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

27.12.24

Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag

27.12.24

Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste

27.12.24

Freitagshandel in Frankfurt: LUS-DAX zeigt sich letztendlich fester

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Sanofi S.A.

Aktien Top/Flop

Sanofi Peer Group Nachrichten

Meistgelesene Nachrichten